TrialEuropean journal of clinical pharmacology2015

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.